How to Get Lisinopril in Maryland: Prescriptions, Telehealth, and Pharmacies

What Lisinopril Is and Why Maryland Prescribers Use It

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor approved by the FDA for hypertension, heart failure, and acute myocardial infarction. It is also widely used off-label for diabetic nephropathy and chronic kidney disease (CKD) progression. The drug works by blocking the conversion of angiotensin I to angiotensin II, which reduces peripheral vascular resistance and lowers blood pressure. [1]

The ALLHAT trial (N=33,357) published in JAMA in 2002 compared chlorthalidone, amlodipine, lisinopril, and doxazosin for major coronary events in high-risk hypertensive patients. Chlorthalidone was superior on some secondary endpoints, but lisinopril produced equivalent rates of fatal coronary heart disease and nonfatal myocardial infarction (relative risk 0.99 to 95% CI 0.91 to 1.08), confirming its first-line status. [2]

The American College of Cardiology/American Heart Association 2017 hypertension guideline designates ACE inhibitors as a preferred first-line agent for adults with hypertension and comorbid CKD, diabetes, or reduced ejection fraction heart failure. [3] The Centers for Disease Control and Prevention estimates that 34.4% of Maryland adults have hypertension, making lisinopril one of the most commonly prescribed drugs in the state. [4]

Lisinopril is available generically from multiple manufacturers at most Maryland pharmacies, typically for under $10 for a 30-day supply at common retail chains. [5]

Who Can Prescribe Lisinopril in Maryland

Any Maryland-licensed physician (MD or DO), nurse practitioner (NP), or physician assistant (PA) can write a lisinopril prescription. Maryland law grants full prescriptive authority to NPs operating under a Collaborative Practice Agreement or, for certified nurse practitioners with sufficient experience, independent prescriptive authority. PAs in Maryland must work under a supervising physician relationship but can independently prescribe Schedule V and non-scheduled drugs including lisinopril. [6]

Dentists and optometrists in Maryland do not have authority to prescribe antihypertensives. A licensed clinical pharmacist with a Collaborative Drug Therapy Management (CDTM) agreement may titrate lisinopril dosing under an existing prescription but cannot initiate a new prescription independently. [7]

Telehealth prescribers must hold an active Maryland Board of Physicians or Maryland Board of Nursing license. The prescriber does not need to be physically located in Maryland, only licensed there. An out-of-state provider who treats a Maryland patient via telehealth must obtain a Maryland license or hold a valid Interstate Medical Licensure Compact (IMLC) license covering Maryland. [8]

How to Get a Lisinopril Prescription in Maryland: Step by Step

Getting a prescription follows a clear sequence regardless of whether you see a provider in person or online.

Step 1: Schedule a visit. Book either an in-person appointment with a primary care physician or a telehealth visit through a Maryland-licensed platform. Most synchronous video visits for straightforward hypertension last 15 to 20 minutes.

Step 2: Complete intake labs. A basic metabolic panel (BMP) measuring serum creatinine, potassium, and eGFR is recommended before starting lisinopril. The National Kidney Foundation guidance recommends baseline eGFR and urinary albumin-to-creatinine ratio (UACR) for all patients with CKD or diabetes starting an ACE inhibitor. [9] Many telehealth platforms send an electronic lab order to a LabCorp or Quest location near you before the visit.

Step 3: Clinical evaluation. The provider reviews blood pressure readings (at least two readings on two separate days are preferred per JNC 8 guidance), [10] your medication history, and any contraindications such as history of angioedema, bilateral renal artery stenosis, or pregnancy.

Step 4: Prescription sent to pharmacy. Maryland law requires Schedule II prescriptions to be sent electronically, but lisinopril is non-scheduled. Providers may send it electronically, by phone, or on paper. Electronic prescribing is standard practice at all major telehealth platforms and most in-person clinics.

Step 5: Receive medication. A retail pharmacy fills same-day or next-day. Mail-order pharmacies such as Express Scripts or CVS Caremark typically deliver within 5 to 7 business days.

Telehealth Providers Prescribing Lisinopril in Maryland

Maryland adopted a permanent telehealth framework after the COVID-19 public health emergency, allowing synchronous audio-video and, in some circumstances, audio-only consultations for established patients. [11] Telehealth prescribing of non-controlled medications like lisinopril is fully permitted for both new and established patients.

Several national telehealth platforms hold Maryland state licensure and can prescribe lisinopril:

• HealthRX offers a dedicated hypertension management program pairing a Maryland-licensed prescriber with a care coordinator, typically completing intake within 24 hours.
• Teladoc Health and MDLive both employ Maryland-licensed physicians and NPs for urgent and primary care visits.
• Hims & Hers Health offers a blood pressure program in Maryland that includes baseline lab ordering.

For a telehealth visit to result in a lisinopril prescription without a prior in-person exam, the provider must determine that a prescribing decision can be made safely based on the available information. The Maryland Board of Physicians guidance states that the standard of care for telehealth must be equivalent to in-person care. [12] This means the provider will review uploaded blood pressure logs, prior lab results, and may request in-person follow-up if clinical uncertainty exists.

HealthRX Hypertension Intake Framework (Maryland patients):

1. Patient submits blood pressure logs from the prior 7 days (minimum 6 readings).
2. Lab results less than 90 days old are reviewed; if absent, an order is placed at a local draw site.
3. Prescriber conducts a synchronous video visit.
4. If eGFR is 30 mL/min/1.73m² or higher, lisinopril 10 mg daily is a standard starting point.
5. A 90-day supply is sent to the patient's preferred pharmacy or mailed via a partnered pharmacy.
6. A 4-week follow-up is scheduled to review blood pressure response and repeat BMP.

Labs Required Before Starting Lisinopril in Maryland

Baseline laboratory testing reduces the risk of two primary ACE inhibitor adverse effects: hyperkalemia and acute kidney injury. The FDA prescribing information for lisinopril recommends monitoring serum potassium and renal function before initiation and periodically thereafter. [1]

Recommended pre-treatment labs include:

• Comprehensive or basic metabolic panel (CMP/BMP): Establishes baseline creatinine, blood urea nitrogen (BUN), potassium, and sodium.
• eGFR: Calculated from creatinine. Lisinopril can be started in most patients with CKD stages 1 to 3b (eGFR 30 to 89 mL/min/1.73m²) with monitoring. Caution is warranted at eGFR <30. [9]
• Urinalysis with microalbumin (for diabetic or CKD patients): Establishes baseline proteinuria, since ACE inhibitors reduce UACR in diabetic nephropathy by roughly 35% compared with placebo per a 2001 meta-analysis in the Annals of Internal Medicine. [13]
• Pregnancy test: Lisinopril is FDA Category D for pregnancy and is absolutely contraindicated. [1]

Follow-up BMP is recommended 1 to 2 weeks after starting therapy, especially in patients with CKD, diabetes, or baseline potassium above 4.5 mEq/L. [14]

Maryland Medicaid and Insurance Coverage for Lisinopril

Maryland Medicaid (HealthChoice) covers lisinopril for approved indications but may require prior authorization (PA) for some managed care organizations (MCOs) within the program. The three primary covered indications are hypertension, systolic heart failure (HFrEF), and CKD with proteinuria. [15]

What prior authorization documentation typically requires:

• Documented diagnosis using ICD-10 codes (I10 for essential hypertension, I50.20 for systolic heart failure, N18.3 through N18.5 for CKD stages 3 to 5).
• Blood pressure readings confirming inadequate control or a compelling indication.
• Confirmation that the patient is not pregnant and has no history of ACE inhibitor-induced angioedema.
• Recent BMP results (typically within 90 days).

The Maryland Medicaid Preferred Drug List (PDL) places generic lisinopril in Tier 1 for most MCOs, meaning PA is often bypassed for the generic 10 mg and 20 mg formulations for straightforward hypertension. PA is more commonly triggered for high-dose lisinopril (40 mg) or when combining lisinopril with an ARB. [15]

Most private Maryland insurers (CareFirst BlueCross BlueShield, Kaiser Permanente of the Mid-Atlantic States, United Healthcare of the Mid-Atlantic) place generic lisinopril on Tier 1 with a $0 to $10 copay. [16]

Transferring a Lisinopril Prescription to Maryland

Transferring a lisinopril prescription from another state to a Maryland pharmacy is straightforward because lisinopril is a non-controlled substance.

Under Maryland pharmacy law, a receiving pharmacy may accept a transferred prescription from any out-of-state pharmacy. [17] The transfer is completed pharmacist-to-pharmacist. You do not need a new prescription from a Maryland provider unless the original prescription has no remaining refills.

Practical steps to transfer:

1. Contact the Maryland pharmacy (in person, by phone, or via the chain's app).
2. Provide the name of your current pharmacy, your prescription number, and the prescriber's name.
3. The Maryland pharmacist contacts the originating pharmacy and records the transfer.
4. The original pharmacy must cancel its record of the prescription once transferred, per federal pharmacy regulations. [17]

If your prescription has expired or has no refills remaining, you will need a new evaluation from a Maryland-licensed provider. A telehealth visit is the fastest route in that scenario.

Chain pharmacies in Maryland (CVS, Walgreens, Rite Aid, Giant Food Pharmacy) can also transfer within their own network electronically without a pharmacist-to-pharmacist call, using their internal database systems.

503A Compounding Pharmacies in Maryland and Lisinopril

The majority of patients receive commercially manufactured generic lisinopril tablets. A small subset, such as pediatric patients requiring weight-based dosing or adults with swallowing difficulties, may need a compounded oral liquid formulation.

Maryland-licensed 503A compounding pharmacies can legally prepare lisinopril oral solutions on a patient-specific basis with a valid prescription. The FDA defines 503A pharmacies as traditional compounding pharmacies that compound for individual patients and are regulated primarily by state boards of pharmacy. [18]

Lisinopril is not on the FDA's list of drugs that may not be compounded under section 503A of the Federal Food, Drug, and Cosmetic Act, meaning it remains eligible for 503A compounding. [18] Maryland's Board of Pharmacy oversees 503A compounders operating in the state and requires compliance with USP Chapter 795 standards for non-sterile preparations. [19]

A typical compounded lisinopril oral suspension is 1 mg/mL or 2 mg/mL, prepared in a flavored vehicle such as Ora-Plus/Ora-Sweet. The prescriber should specify the concentration, volume, and flavor on the prescription.

503B outsourcing facilities (large-scale compounders regulated federally by FDA) do not typically stock lisinopril for office use because commercial generic tablets are readily available and inexpensive. If a 503A compounder in Maryland is unavailable, a compound can be shipped from a licensed 503A pharmacy in another state, provided the receiving state (Maryland) permits such shipments and the pharmacy holds any required out-of-state licenses. [18]

How Long Until You Receive Lisinopril in Maryland

Time from first contact to medication in hand depends on the access path.

• Retail pharmacy (in-person visit, same day): 30 minutes to 2 hours after the visit if the prescription is sent electronically.
• Telehealth visit, retail pharmacy pickup: 3 to 24 hours if labs are already on file. If new labs are required first, add 1 to 3 business days for a local draw site.
• Telehealth visit, mail-order pharmacy: 5 to 10 business days for standard delivery; 2 to 3 business days for expedited shipping.
• Prior authorization required (Medicaid or select private plans): 3 to 5 business days for standard PA review; Maryland Medicaid MCOs are required to respond to urgent PA requests within 24 hours under COMAR 10.09.67. [15]

Most patients without PA requirements and with existing labs receive lisinopril within 24 hours of their telehealth consultation.

Monitoring After You Start Lisinopril

Starting lisinopril is not a one-time event. A 2019 review in the Journal of the American College of Cardiology found that ACE inhibitor-induced acute kidney injury occurs in roughly 0.4% to 1.5% of outpatient initiations, most within the first 30 days. [20]

Standard monitoring milestones:

• 1 to 2 weeks post-initiation: Repeat BMP to check creatinine, potassium, and eGFR. A serum creatinine rise of up to 30% above baseline is considered acceptable and does not require discontinuation per KDIGO 2024 CKD guidelines. [21] A rise above 30% or new potassium above 5.5 mEq/L warrants dose reduction or discontinuation.
• 4 weeks: Blood pressure recheck. Target is <130/80 mmHg for most adults per the 2017 ACC/AHA guideline. [3]
• Every 6 to 12 months (stable patients): Annual BMP and blood pressure review.

Patients should be counseled about two specific adverse effects. First, a dry, persistent cough occurs in 5% to 20% of patients and is a class effect of ACE inhibitors, not dose-dependent, and resolves after switching to an ARB. [22] Second, angioedema (swelling of the lips, tongue, or throat) occurs in 0.1% to 0.7% of patients and is more common in Black patients; it requires immediate discontinuation and emergency care. [23]

Dose Titration for Common Maryland Indications

The FDA-approved dosing for lisinopril differs by indication. [1]

• Hypertension: Initial dose 10 mg once daily; target dose 20 to 40 mg once daily. Maximum approved dose is 40 mg/day.
• Heart failure (adjunct therapy): Initial dose 2.5 to 5 mg once daily; target dose 20 to 40 mg once daily per the 2022 AHA/ACC Heart Failure guideline. [24]
• Acute MI (within 24 hours): 5 mg within 24 hours, then 5 mg at 24 hours, then 10 mg at 48 hours, then 10 mg once daily for 6 weeks.
• Diabetic nephropathy (off-label): 10 to 40 mg once daily to reduce UACR and slow eGFR decline. [13]

Dose adjustments are required for renal impairment. For eGFR <30 mL/min/1.73m², the starting dose is typically 2.5 mg once daily and titration is slower with closer monitoring. [1]